One in five people over 65 and one in four people over 75 are affected by diabetes. Global projections predict a 2.5-fold increase in diabetes prevalence over the next 25 years. Among older people with diabetes, 30-45% are affected by frailty (Frailty) The risk of frailty increases with increasing HbA1c. The incidence of atherosclerotic cardiovascular disease (ASCVD) doubles with age, with a prevalence of 38.5% for coronary heart disease (CHD), 13% for stroke and 12% for peripheral arterial disease (PAD) in people aged ≥70 years. In addition to their glucose-controlling effect, new antidiabetic drugs have organ-protective benefits and have brought about a paradigm shift in diabetology.
Autoren
- Dr. med. Young Hee Lee-Barkey
- PD Dr. rer. nat. Bernd Stratmann
- Prof. Dr. med. Susanne Reger-Tan
Publikation
- CARDIOVASC
Related Topics
You May Also Like
- Follow-up care for head and neck cancer
What is the significance of FDG PET-CT?
- Important basics and studies on cancer and the psyche
Interplay between cancer and mental illness
- Systemic lupus erythematosus
Increased risk of pulmonary manifestations
- Postmenopausal osteoporosis: long-term therapy concepts
Targeted use of antiresorptives and osteoanabolic agents and avoid “rebound” effects
- Late-onset rheumatoid arthritis
More DMARDs can reduce glucocorticoids in LORA
- Atopic dermatitis
Implement the “minimal disease activity” concept
- Sensation of pain
Special features for people with multiple disabilities
- Atopic dermatitis